Please assess the completion status of the following clinical trial:

Trial Title: Silver Impregnated Dressings to Reduce Wound Complications in Obese Patients at Cesarean Section

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Undergoing cesarean section (with or without concurrent tubal ligation)~* Body mass index (based on most recent weight) \>=30~Exclusion Criteria:~* Known allergy to silver~* Less than 18 years of age~* Preoperative evidence of current abdominal wall infection~* Contraindication to closure of the skin at time of surgery~* Plan to perform procedures in addition to cesarean section (with or without tubal ligation)~* Patients with previously placed abdominal wall mesh at site of planned surgery~* Inability to participate in medical decision making~* Inability to follow up with the Michigan Visiting Nurses or are unable to return to the University of Michigan Medical Center for staple removal

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Standard Dressing (Type: PLACEBO_COMPARATOR): Obese patients undergoing cesarean section in this arm will receive a standard island-type dressing
- Silverlon (Type: EXPERIMENTAL): Obese patients undergoing cesarean section in this arm will receive Silverlon, a silver impregnated dressing

Based on this trial design, predict the completion outcome and termination type (if applicable).